Skip to content

Physician Use and Perceptions of GLP-1 Drugs for Weight Loss

Thank you for taking the time to participate in this survey from Medical Economics and Patient Care Online. Your insights will help us better understand the impact and usage of GLP-1 receptor agonists (GLP-1 RAs) for management of obesity among physicians.
1.What is your specialty?(Required.)
2.Have you prescribed GLP-1 RAs to treat obesity in your practice?(Required.)
3.How often do your patients inquire about GLP-1 RAs for weight loss?(Required.)
4.Do the patients who inquire about GLP-1 RAs meet the criteria for overweight/obesity indicated in labeling of the medications? (Required.)
5.Do you feel patients have realistic expectations of the weight loss outcomes associated with use of GLP-1 RAs? (Required.)
6.Are you concerned about your patients attempting to procure GLP-1 RAs from online sources without your knowledge?(Required.)
7.How do you typically integrate GLP-1 RAs into your treatment plans for management of obesity? (Required.)
8.How often, in your experience, do your patients prescribed GLP-1 RAs experience significant adverse effects? (Required.)
9.How effective do you find GLP-1 RAs in achieving weight loss goals for your patients?(Required.)
10.Do you consider GLP-1 RAs to be cost-effective for weight loss? (Required.)
11.Do your patients frequently face insurance coverage challenges when obtaining GLP-1 RAs?(Required.)
12.Do you anticipate the use of GLP-1 RAs for weight loss increasing in the future?(Required.)
13.As a physician, what do you see as the most pressing unanswered question about the use of GLP-1 RAs for weight loss?